
New Capital Partners
Description
New Capital Partners (NCP) is a well-established private equity firm based in Birmingham, Alabama, founded in 1997. The firm focuses on growth equity and recapitalization transactions within the lower middle market. NCP primarily seeks to partner with companies in the healthcare, financial technology, and business services sectors, aiming to provide strategic capital and operational support to facilitate growth and market expansion. Their long-standing presence in the private equity landscape underscores a consistent investment philosophy centered on value creation in specific, high-growth industries.
NCP's investment strategy is clearly defined, targeting companies that demonstrate strong financial performance and significant growth potential. Specifically, the firm looks for businesses with revenues ranging from $10 million to $50 million and EBITDA between $2 million and $10 million. This focus on the lower middle market allows NCP to engage with companies that may be overlooked by larger funds but possess substantial opportunities for scaling. Their typical equity investment per transaction falls within the range of $10 million to $30 million, indicating their capacity to be a significant capital partner for their portfolio companies.
Since its inception, New Capital Partners has built a robust track record, having invested in over 35 companies across its target sectors. The firm has successfully raised over $500 million in capital across its various funds, demonstrating strong investor confidence and a solid financial base for future investments. While their primary geographic focus is the Southeastern U.S., NCP also pursues opportunities on a national scale, broadening their reach for promising ventures. This comprehensive approach, combined with their sector-specific expertise, positions NCP as a strategic partner for lower middle market companies seeking capital for growth or ownership transitions.
Investor Profile
New Capital Partners has backed more than 25 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 36% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Private Equity, Series B rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Health Care, Hospital, Information Technology.
- Typical check size: $10M – $30M.
Stage Focus
- Series Unknown (36%)
- Private Equity (32%)
- Series B (12%)
- Series C (8%)
- Series A (8%)
- Debt Financing (4%)
Country Focus
- United States (96%)
- United Kingdom (4%)
Industry Focus
- Health Care
- Hospital
- Information Technology
- Marketing
- Medical
- Mental Health
- Biotechnology
- Mhealth
- Telehealth
- Finance
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.